Rama K. Gurram, PhD
Rama K. Gurram, Ph.D. Laboratory of Molecular Immunology, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, USA Dr. Gurram received his Ph.D. in Immunology from the Jawaharlal …
Katherine A. Waugh, PhD
Katherine A. Waugh, Ph.D. Department of Pharmacology, University of Colorado – Anschutz Medical Campus, USA Dr. Waugh is an Instructor at the Linda Crnic Institute for Down Syndrome and the …
Shehneela Baseer
Shehneela Baseer Hannover Medical School, Germany Shehneela is doing her Ph.D. at Hannover Medical School, Germany. Her Ph.D. research focuses on the developing a deep understanding of the immune response …
Erwin Le Scolan, PhD
Erwin Le Scolan CytomX Therapeutics, South San Francisco, USA Dr. Le Scolan has over 15 years of research experience in immuno-oncology. He joined CytomX in 2017 as a Scientist in …
Venkat Giri Magupalli, PhD
Venkat Giri Magupalli Department of Pediatrics, Harvard Medical School, Boston, USA Venkat Giri Magupalli is an Assistant Professor at Harvard Medical School in the Department of Pediatrics. His research focuses …
Olivia Luise Gern
Olivia Luise Gern Veterinary University of Hannover, Germany Olivia Luise Gern obtained her Bachelor’s degree in Life Science in Lille, France, where she focused on cell biology and physiology. Since …
Damian Bertheloot, PhD
Damian Bertheloot, Ph.D. Institute of Innate Immunity, Bonn, Germany Dr. Damien Bertheloot is passionate about the signature dying cells leave behind and the impact these molecular patterns have on the …
25th Annual Woods Hole Immunoparasitology 2022 Meeting Summary
FOCIS 2022 Member Society Symposium
Human Cytokine Deficiencies and Cytokinopathies
Presented by The International Cytokine & Interferon Society
Symposium Chairs: Dusan Bogunovic, – Icahn School of Medicine at Mount Sinai and Kate Jeffrey, Moderna/Harvard University
The International Cytokine & Interferon Society (ICIS) Member Society Symposium at FOCIS 2022 will feature the newest research devoted to human cytokine deficiencies and cytokanopathies alike, both of which impact human health, provide insight into fundamental biological principles, and offer targets for therapy of rare and common diseases.